Selected article for: "Coronavirus pandemic and entire world"

Author: Lai, Quirino; Spoletini, Gabriele; Bianco, Giuseppe; Graceffa, Dario; Agnes, Salvatore; Rossi, Massimo; Lerut, Jan
Title: SARS‐CoV2 and immunosuppression: a double‐edged sword
  • Cord-id: zpgvh8ta
  • Document date: 2020_7_8
  • ID: zpgvh8ta
    Snippet: Severe acute respiratory syndrome Coronavirus 2 (SARS‐Cov2) outbreak has caused a pandemic rapidly impacting on the way of life of the entire world. This impact in the specific setting of transplantation and immunosuppression has been poorly explored to date. Discordant data exist on the impact of previous coronavirus outbreaks on immunosuppressed patients. Overall, only a very limited number of cases have been reported in literature, suggesting that transplanted patients not necessarily prese
    Document: Severe acute respiratory syndrome Coronavirus 2 (SARS‐Cov2) outbreak has caused a pandemic rapidly impacting on the way of life of the entire world. This impact in the specific setting of transplantation and immunosuppression has been poorly explored to date. Discordant data exist on the impact of previous coronavirus outbreaks on immunosuppressed patients. Overall, only a very limited number of cases have been reported in literature, suggesting that transplanted patients not necessarily present an increased risk of severe SARS‐Cov2‐related disease compared to the general population. We conducted a literature review related to the impact of immunosuppression on coronavirus infections including case reports and series describing immunosuppression management in transplant recipients. The role of steroids, calcineurin inhibitors and mycophenolic acid has been explored more in detail. A point‐in‐time snapshot of the yet released literature and some considerations in relation to the use of immunosuppression in SARS‐Cov2 infected transplant recipients are provided here for the physicians dealing with immunocompromised patients.

    Search related documents:
    Co phrase search for related documents
    • aasld liver diseases study and liver diseases: 1, 2, 3
    • acute ards respiratory distress syndrome and adrenal insufficiency: 1, 2, 3
    • acute ards respiratory distress syndrome and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • acute ards respiratory distress syndrome and liver disease patient: 1
    • acute ards respiratory distress syndrome and liver diseases: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and low incidence: 1, 2, 3, 4, 5, 6
    • acute respiratory infection and adrenal insufficiency: 1, 2, 3
    • acute respiratory infection and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory infection and liver disease patient: 1, 2
    • acute respiratory infection and liver diseases: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute respiratory infection and liverpool university: 1
    • acute respiratory infection and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory infection and low incidence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • liver disease and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • liver diseases and lopinavir ritonavir: 1, 2, 3, 4
    • liverpool university and lopinavir ritonavir: 1, 2